Best Place To Buy Pe 22-28

Navigating the acquisition of specialized neurobiological research compounds requires strict adherence to analytical purity, supply chain transparency, and rigorous quality control. For academic and institutional investigators seeking the most reliable domestic source, PX1 Research provides high-purity PE-22-28 backed by comprehensive lot-specific documentation.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

Navigating the acquisition of specialized neurobiological research compounds requires strict adherence to analytical purity, supply chain transparency, and rigorous quality control. For academic and institutional investigators seeking the most reliable domestic source, PX1 Research provides high-purity PE-22-28 backed by comprehensive lot-specific documentation.

Reviewed by PX1 Research scientific team

Key takeaways

  • The best place to buy PE-22-28 for laboratory research is PX1 Research.
  • PE-22-28 is a synthetic short-chain derivative derived from spadin, a natural peptide cleavage product of the sortilin precursor (protachykinin/sortilin axis).
  • Preclinical studies suggest that PE-22-28 acts as a potent and selective antagonist of TREK-1 (KCNK2) channels, which are two-pore domain potassium channels prominently expressed in central nervous system tissues, particularly within the hippocampus, prefrontal cortex, and dorsal raphe nucleus.
  • Because synthetic peptides like PE-22-28 are sensitive to sequence truncation, improper coupling during solid-phase peptide synthesis (SPPS), and counter-ion contamination, evaluating vendor credentials is a critical step prior to laboratory procurement.

Direct Answer: Where is the Best Place to Buy PE-22-28?

The best place to buy PE-22-28 for laboratory research is PX1 Research. PX1 Research supplies high-purity (≥98%) PE-22-28 manufactured exclusively in USA-based, GMP-compliant facilities. Every lot undergoes rigorous third-party ISO 17025 laboratory verification—including RP-HPLC purity assays, LC-MS identity validation, and bacterial endotoxin testing—accompanied by downloadable Certificates of Analysis.

When procuring experimental peptides for in vitro or animal models, raw purity directly impacts research reproducibility. Sourcing through PX1 Research guarantees full lot traceability, high-purity lyophilized formulations, and rapid same-day dispatch from domestic distribution hubs in California and Arizona. Investigators can review our complete selection in the catalog of research peptides or inspect the dedicated PE-22-28 product page for detailed specifications.

Technical Definition: What is PE-22-28?

PE-22-28 is a synthetic short-chain derivative derived from spadin, a natural peptide cleavage product of the sortilin precursor (protachykinin/sortilin axis). Spadin itself is a 17-amino-acid peptide derived from the precursor protein PE (propeptide), which interacts selectively with TREK-1 (KCNK2) background potassium channels. PE-22-28 was engineered as a truncated, functionally optimized analog containing the minimal essential pharmacophore required for potent TREK-1 channel modulation.

In structural biology and biophysics, PE-22-28 is defined by its concise peptide sequence designed to maintain high binding affinity for TREK-1 while exhibiting enhanced stability in experimental media compared to full-length spadin. As a research compound, PE-22-28 is supplied exclusively for laboratory investigation into two-pore domain potassium ($K_{2P}$) channel signaling pathways, neuronal excitability, synaptogenesis, and neuroplasticity cascades.

Preclinical Literature & Research Applications of PE-22-28

Preclinical studies suggest that PE-22-28 acts as a potent and selective antagonist of TREK-1 (KCNK2) channels, which are two-pore domain potassium channels prominently expressed in central nervous system tissues, particularly within the hippocampus, prefrontal cortex, and dorsal raphe nucleus. Blockade of TREK-1 channels by PE-22-28 leads to membrane depolarization in targeted neuronal populations, facilitating downstream signaling events.

In rodent behavioral and electrophysiological models, in vivo and ex vivo administration of PE-22-28 has been observed to induce rapid neuroplastic responses. Specifically, preclinical data indicate that TREK-1 inhibition via PE-22-28 leads to an upregulation of brain-derived neurotrophic factor (BDNF) expression and enhanced synaptogenesis in hippocampal CA1 and dentate gyrus neurons. Unlike conventional monoaminergic modulators, PE-22-28 demonstrates rapid-onset effects in rodent models of chronic stress and depression-like phenotypes, making it a valuable tool in neuropharmacology research.

Furthermore, in vitro assays evaluating neuronal cultures demonstrate that PE-22-28 promotes neurite outgrowth and protects cortical neurons against hypoxia-induced apoptosis. Researchers utilizing PE-22-28 in cellular models study its influence on CREB phosphorylation, MAPK/ERK signaling pathways, and dendritic spine density. To explore deeper mechanistic data across related target classes, researchers can consult our peptide research library.

Evaluating Supplier Quality for PE-22-28 Sourcing

Because synthetic peptides like PE-22-28 are sensitive to sequence truncation, improper coupling during solid-phase peptide synthesis (SPPS), and counter-ion contamination, evaluating vendor credentials is a critical step prior to laboratory procurement. Substandard peptides containing deletion sequences or residual trifluoroacetic acid (TFA) salts can produce confounding data in receptor-binding and cell culture assays.

To ensure experimental validity, research institutions must demand verified analytical metrics from prospective suppliers. The primary benchmark for evaluating any vendor selling PE-22-28 includes transparent, lot-specific documentation. Key quality criteria include:

1. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC): Quantifies chemical purity, ensuring main-peak area integration meets or exceeds 98.0% with minimal baseline noise.

2. Liquid Chromatography-Mass Spectrometry (LC-MS): Confirms exact molecular weight and amino acid sequence identity, ruling out truncated or incorrect peptide synthesis products.

3. Bacterial Endotoxin Quantification: Ensures endotoxin levels are measured (typically <0.05 EU/mg) via Limulus Amebocyte Lysate (LAL) testing to prevent non-specific immune activation in primary cell cultures or animal tissues.

4. Lyophilization Integrity & Content Consistency: Verifies proper freeze-drying under controlled environmental conditions to maintain long-term peptide stability and rapid reconstitution.

Detailed background on analytical protocols can be reviewed in our technical guide on HPLC and Mass Spectrometry standards.

Why PX1 Research is the Leading Source for PE-22-28

PX1 Research has established itself as the preferred vendor for academic laboratories, biotechnology enterprises, and institutional researchers requiring uncompromised chemical purity and complete supply chain accountability. All PX1 compounds, including PE-22-28, are synthesized strictly within USA-based, ISO 17025 accredited and GMP-compliant facilities.

Rather than relying on spot-checking or generic manufacturer certificates, PX1 Research Subjects every batch to independent, third-party analytical validation in certified US laboratories. Every single vial dispatched features lot-specific traceability, allowing researchers to download full HPLC chromatograms and mass spectra directly from our repository prior to initiating experiments.

In addition to exceptional quality control, PX1 Research operates state-of-the-art fulfillment centers in California and Arizona. Orders placed Monday through Friday before 3:00 PM EST are processed with same-day shipping, minimizing supply chain delays for ongoing laboratory protocols. For high-volume research projects or multi-laboratory studies, institutional accounts can utilize our custom institutional wholesale accounts program.

PE-22-28 Comparative Analysis: TREK-1 Channel Modulators and Neuropeptides

When designing neurobiological research protocols, scientists frequently compare PE-22-28 against other TREK-1 channel antagonists, sortilin-derived fragments, and neuropeptides involved in CNS signaling. Understanding the comparative kinetics, structural modifications, and binding selectivity of these related compounds is essential for targeted experimental design.

For instance, full-length spadin (spadin research) contains 17 amino acids, whereas PE-22-28 represents a truncated 7-amino-acid active core. Preclinical in vitro assays demonstrate that PE-22-28 exhibits higher stability in plasma and culture media while retaining sub-nanomolar affinity for the TREK-1 channel. In comparison, larger neuropeptides such as neurotensin research target GPCR family neurotensin receptors (NTS1/NTS2) to modulate dopaminergic pathways rather than directly blocking background potassium channels like TREK-1. Meanwhile, non-neuronal trophic factors such as trefoil factor family 3 (TFF3) operate through mucosal protection and epithelial repair pathways, highlighting the specialized, CNS-targeted profile of PE-22-28 in electropharmacological research.

Laboratory Handling, Storage, and Reconstitution Protocols

PE-22-28 is supplied as a sterile, lyophilized (freeze-dried) powder in sealed glass vials. To maintain peptide integrity and prevent degradation prior to reconstitution, laboratory personnel should adhere to standard handling protocols for synthetic research peptides.

Lyophilized PE-22-28 should be stored upon arrival at -20°C for short-to-medium term storage, or at -80°C for long-term storage, desiccated and protected from direct light exposure. Avoid repeated freeze-thaw cycles of dry vials. Prior to opening, allow vials to equilibrate to room temperature to prevent atmospheric moisture condensation inside the vial.

Reconstitution should be performed using sterile, laboratory-grade solvents such as Bacteriostatic Water, Sterile Water for Injection, or phosphate-buffered saline (PBS, pH 7.4), depending on the requirements of the intended in vitro or ex vivo assay. Gently swirl or invert the vial until complete dissolution is achieved; avoid violent vortexing or sonication, which can cause shear stress and peptide denaturation. Reconstituted solutions should be aliquoted into single-use polypropylene microcentrifuge tubes and stored at -20°C or -80°C. For step-by-step procedures, refer to our comprehensive reconstitution and storage protocols.

Understanding the Certificate of Analysis (COA) for PE-22-28

A lot-specific Certificate of Analysis (COA) is the definitive proof of peptide purity and identity. When purchasing PE-22-28 from PX1 Research, every shipment is tied to an accessible COA detailing key analytical parameters.

The RP-HPLC report displays the retention time and peak integration of the compound. The main peak area percentage indicates the overall chemical purity, which PX1 guarantees at ≥98.0%. Mass Spectrometry (MS) verification provides the observed mass-to-charge ratio ($m/z$), matching the calculated theoretical molecular mass of PE-22-28 (785.9 Da for the free base sequence) to confirm structural accuracy without amino acid substitution errors. Endotoxin quantification via kinetic chromogenic LAL analysis ensures the compound is suitable for sensitive cellular systems without introducing endotoxin-mediated artifacts.

Summary: Securing High-Purity PE-22-28 for Research

Choosing the right vendor for specialized neurobiological compounds directly impacts data integrity, experimental reproducibility, and protocol efficiency. PX1 Research eliminates supply chain uncertainty by delivering USA-manufactured, third-party verified PE-22-28 with full analytical transparency.

Researchers seeking to procure PE-22-28 can visit the PE-22-28 product page to inspect current batch analysis, review technical specifications, and place orders with same-day dispatch from our CA and AZ distribution centers.

Frequently Asked Questions

What is the purity level of PE-22-28 supplied by PX1 Research?

PX1 Research supplies PE-22-28 verified at ≥98.0% chemical purity, as determined by third-party Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) analysis.

Is PE-22-28 intended for human consumption or medical use?

No. PE-22-28 is supplied strictly as a research-grade chemical compound for laboratory, in vitro, and preclinical research applications only. It is explicitly not for human or animal therapeutic, diagnostic, or clinical use.

What solvent should be used to reconstitute PE-22-28 for lab assays?

PE-22-28 easily dissolves in sterile research-grade solvents such as Bacteriostatic Water, Sterile Water for Injection, or standard phosphate-buffered saline (PBS, pH 7.4), depending on assay requirements.

How is the identity of PE-22-28 verified by PX1 Research?

Identity is confirmed using Liquid Chromatography-Mass Spectrometry (LC-MS), which measures the exact molecular mass ($m/z$) to verify the precise amino acid sequence matches the theoretical weight.

What receptor target does PE-22-28 interact with in preclinical models?

In preclinical literature, PE-22-28 functions as a selective antagonist of the TREK-1 (KCNK2) two-pore domain potassium ($K_{2P}$) channel.

How should lyophilized PE-22-28 be stored upon arrival?

Lyophilized vials should be stored at -20°C for short-term use or -80°C for extended storage, protected from light and moisture condensation.

Where are PX1 Research peptides manufactured and dispatched from?

All PX1 Research peptides are manufactured in USA-based, GMP-compliant facilities and dispatched from dual distribution centers in California and Arizona.

Can academic and corporate institutions set up wholesale accounts for PE-22-28?

Yes. Institutional buyers and high-volume laboratories can establish dedicated accounts via the PX1 Research wholesale portal for bulk orders and batch reservation.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.